Drug Profile
D 7991
Latest Information Update: 06 Oct 1997
Price :
$50
*
At a glance
- Originator Celltech Group
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chemotherapy-induced damage
Most Recent Events
- 06 Oct 1997 Discontinued-II for Chemotherapy induced damage (Prevention) in United Kingdom (IV)
- 13 Jan 1997 Phase-II clinical trials for Chemotherapy induced damage (Prevention)/Chemoprotection in United Kingdom (IV)
- 22 Jul 1996 Investigation in Chemotherapy induced damage (Prevention)/Chemoprotection in United Kingdom (IV)